Physician Wealth Advisors’s CEL-SCI Corp CVM Stock Holding History

Physician Wealth Advisors’s Portfolio CVM Stock Details CVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4	Hold	3	–	–	﹤0.01%	2331
2026 Q1	$10	Hold	3	–	–	﹤0.01%	2053
2025 Q4	$16	Hold	3	–	–	﹤0.01%	2021
2025 Q3	$28	Hold	3	–	–	﹤0.01%	1891
2025 Q2	$7	Hold	3	–	–	﹤0.01%	1795
2025 Q1	$23	Hold	3	–	–	﹤0.01%	1427
2024 Q4	$40	Buy	+3	New	+$69	﹤0.01%	1134

Other funds holding CVM

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return

HHCP

Hilton Head Capital Partners Hilton Head Island, South Carolina $198M AUM

BWS

Buck Wealth Strategies Denver, Colorado $956M AUM 13.47% 1-Year Est. Return

Advisornet Financial Minnetonka, Minnesota $2.19B AUM 21.28% 1-Year Est. Return

GSWM

Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return

Physician Wealth Advisors's CVM Position: Q2 2026 in Review

Physician Wealth Advisors held its CEL-SCI Corp (CVM) position steady in Q2 2026 at 3 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #2331.

Physician Wealth Advisors first reported a position in CVM in Q4 2024 and has held it in 7 quarters since. The position peaked at $40 in Q4 2024. 7 funds tracked by Wall St. Rank hold CVM as of Q2 2026.

Physician Wealth Advisors held 3 shares of CEL-SCI Corp worth $4 as of Q2 2026.
Physician Wealth Advisors left its CEL-SCI Corp share count unchanged in Q2 2026.
CEL-SCI Corp made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #2331 holding.
Physician Wealth Advisors first reported a position in CEL-SCI Corp in Q4 2024 and has held it in 7 quarters since.
Physician Wealth Advisors's CEL-SCI Corp position peaked at $40 in Q4 2024.
7 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.